Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells

Journal of Enzyme Inhibition and Medicinal Chemistry
Ismail KoyuncuClaudiu T Supuran

Abstract

Cervical cancer is a common type of cancer. Carbonic anhydrase IX (CA IX) is an attractive target for tumour therapy, being overexpressed in many cancers. We investigated the anticancer properties of the aromatic sulphonamide S-1 as a CA IX inhibitor on cervical cancer cells (HeLa) positive for CA IX expression and normal prostate epithelial cell line (PNT1-A) negative for CA IX. We examined the cytotoxic, apoptosis, genotoxic, and oxidative stress activity of S-1 on HeLa and PNT1-A cell lines. S-1 induced significant reduction of cell viability, caused apoptosis, and up-regulated ROS production. This decrease in cell survival rate can be attributed to the high level of ROS and apoptosis, which has also been shown to arrest the cell cycle. Our findings indicated that S-1 is more effective on HeLa than PNT1-A. S-1 was able to induce apoptosis of cervical cancer cells and is a possible candidate for future anticancer studies.

References

Jul 15, 1993·European Journal of Biochemistry·H Sies
Feb 7, 1997·Cell·S Nagata
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R P Perez
Mar 7, 2001·Antioxidants & Redox Signaling·M ParolaM U Dianzani
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Jun 20, 2003·Cell Proliferation·Katrien VermeulenZwi N Berneman
Jan 28, 2004·Cell·Nika N Danial, Stanley J Korsmeyer
Oct 27, 2004·Journal of Enzyme Inhibition and Medicinal Chemistry·Silvia PastorekovaClaudiu T Supuran
Oct 11, 2005·Clinical Biochemistry·Ozcan Erel
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·X-Y NiuP Wang
Jun 2, 2007·Biological & Pharmaceutical Bulletin·Xiao-Dong WangJian-Yong Wu
Aug 2, 2007·Journal of Cellular Biochemistry·Han Ching LiuC Andrew van Hasselt
Jan 3, 2008·Nature Reviews. Drug Discovery·Claudiu T Supuran
Sep 8, 2010·Current Pharmaceutical Design·Harun M SaidDirk Vordermark
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 26, 2012·Current Pharmaceutical Design·Zejun Li, Taiwei Chu
Jan 31, 2012·Cellular Signalling·Paul D RayYoshiaki Tsuji
Sep 19, 2012·Bioorganic & Medicinal Chemistry·Mayank AggarwalRobert McKenna
May 1, 2014·World Journal of Obstetrics and Gynecology·Sherri L StewartCheryll C Thomas
Oct 21, 2015·Frontiers in Plant Science·Marcelo FridlenderHinanit Koltai
Aug 2, 2016·Oxidative Medicine and Cellular Longevity·Sergio Di MeoVictor Manuel Victor
Mar 10, 2018·Journal of Bioenergetics and Biomembranes·Yasin TülüceMustafa Durgun

❮ Previous
Next ❯

Citations

Aug 5, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Mikhail KrasavinClaudiu T Supuran
Aug 14, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Giulia RotondiClaudiu T Supuran
Jul 3, 2021·International Journal of Molecular Sciences·Ebru TemizClaudiu T Supuran
Jan 8, 2022·Naunyn-Schmiedeberg's Archives of Pharmacology·Heba Abd Elghany SahyonMohammad M A Mashaly

❮ Previous
Next ❯

Software Mentioned

Cell Analyser
MINITAB
SoftMax Pro

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.